Akinboro O, Drezner N, Amatya A, Runyan J, et al. US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer. J Clin Oncol 2023 May 4:JCO2202509. doi: 10.1200/JCO.22.02509.
PMID: 37141544